Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Annual Information Update

30th Apr 2012 15:57

RNS Number : 3918C
GlaxoSmithKline Capital PLC
30 April 2012
 



 

ANNUAL INFORMATION UPDATE FOR GLAXOSMITHKLINE CAPITAL PLC FOR THE PERIOD 28 APRIL 2011 TO 30 APRIL 2012

 

 

In accordance with the requirements of Prospectus Rule 5.2.1R please find below an Annual Information Update for GlaxoSmithKline Capital plc (the "Company"). The information referred to in this Update was up to date at the time the information was published, but some information may now be out of date.

 

To avoid an unnecessarily lengthy document, the following are summaries of the information and documents published, or made available to the public, by the Company throughout the period 28 April 2011 to 30 April 2012.

 

Announcements made via RNS, a Regulatory Information Service

The announcements listed below were published on the London Stock Exchange via RNS, a Regulatory Information Service and can be obtained from their website www.londonstockexchange.com.

Date

Headline

24/04/2012

Annual Financial Report

03/08/2011

Publication of Prospectus

03/08/2011

Publication of Registration Document

02/08/2011

Half Yearly Report

28/04/2011

Annual Information Update

 

Documents filed at Companies House

 

All documents listed below were filed with the Registrar of Companies in England and Wales on or around the dates indicated, and can be obtained from Companies House via their website www.companieshouse.gov.uk.

 

 

Date

Document Type

Description of Document Filed

27/04/2012

AA

Accounts to 31/12/2011

27/09/2011

AR01

Annual Return

04/05/2011

AA

Accounts to 31/12/2010

Documents sent to shareholders

The following documents were published and/or sent to shareholders:

Date

Document

27/04/2012

Annual Report and Accounts

 

A copy of this Annual Information Update and copies of the documents referred to in it can be obtained from the Company Secretary at the Company's registered office:

 

 

Victoria Whyte

Company Secretary

GlaxoSmithKline Capital plc

980 Great West Road

Brentford

Middlesex

TW8 9GS

 

Tel: 020 8047 5000

 

 

V A Whyte

Company Secretary

 

30 April 2012

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIULLFESSRIIVIF

Related Shares:

Glaxosmsc 5.25%
FTSE 100 Latest
Value8,632.33
Change89.77